Gail K. Mattson

865 total citations
24 papers, 601 citations indexed

About

Gail K. Mattson is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Gail K. Mattson has authored 24 papers receiving a total of 601 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 18 papers in Cellular and Molecular Neuroscience and 7 papers in Organic Chemistry. Recurrent topics in Gail K. Mattson's work include Receptor Mechanisms and Signaling (14 papers), Neuropeptides and Animal Physiology (9 papers) and Neurotransmitter Receptor Influence on Behavior (8 papers). Gail K. Mattson is often cited by papers focused on Receptor Mechanisms and Signaling (14 papers), Neuropeptides and Animal Physiology (9 papers) and Neurotransmitter Receptor Influence on Behavior (8 papers). Gail K. Mattson collaborates with scholars based in United States and Germany. Gail K. Mattson's co-authors include Miles D. Savage, Surbhi Desai, Edwin Conklin, Nicholas J. Lodge, Thaddeus F. Molski, John E. Macor, Ronald J. Mattson, Graham S. Poindexter, Qi Gao and Jonathan L. Ditta and has published in prestigious journals such as Journal of Medicinal Chemistry, European Journal of Pharmacology and Neuropharmacology.

In The Last Decade

Gail K. Mattson

24 papers receiving 583 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gail K. Mattson United States 15 291 203 143 51 50 24 601
Marc A. Bruce United States 16 252 0.9× 197 1.0× 136 1.0× 98 1.9× 56 1.1× 23 717
Giuseppina Sabatino Italy 15 591 2.0× 277 1.4× 88 0.6× 39 0.8× 26 0.5× 53 1.1k
Shouliang Dong China 15 340 1.2× 143 0.7× 259 1.8× 40 0.8× 14 0.3× 53 647
Shu Jie Li China 18 697 2.4× 142 0.7× 137 1.0× 49 1.0× 13 0.3× 55 987
István Teplán Hungary 18 407 1.4× 96 0.5× 133 0.9× 75 1.5× 53 1.1× 68 912
Chhuttan L. Meena India 15 194 0.7× 92 0.5× 128 0.9× 31 0.6× 39 0.8× 32 558
Hidetomo Yokoo Japan 16 515 1.8× 89 0.4× 186 1.3× 25 0.5× 26 0.5× 67 771
Yuki Fujii Japan 17 252 0.9× 173 0.9× 81 0.6× 55 1.1× 12 0.2× 44 664
Ulla Björkroth Sweden 16 361 1.2× 171 0.8× 327 2.3× 79 1.5× 24 0.5× 71 890
Matthew Hart United States 4 374 1.3× 264 1.3× 137 1.0× 33 0.6× 39 0.8× 7 817

Countries citing papers authored by Gail K. Mattson

Since Specialization
Citations

This map shows the geographic impact of Gail K. Mattson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gail K. Mattson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gail K. Mattson more than expected).

Fields of papers citing papers by Gail K. Mattson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gail K. Mattson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gail K. Mattson. The network helps show where Gail K. Mattson may publish in the future.

Co-authorship network of co-authors of Gail K. Mattson

This figure shows the co-authorship network connecting the top 25 collaborators of Gail K. Mattson. A scholar is included among the top collaborators of Gail K. Mattson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gail K. Mattson. Gail K. Mattson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Hong, Andrew P. Degnan, Anand Balakrishnan, et al.. (2016). Oxazolidinone-based allosteric modulators of mGluR5: Defining molecular switches to create a pharmacological tool box. Bioorganic & Medicinal Chemistry Letters. 26(17). 4165–4169. 21 indexed citations
2.
Degnan, Andrew P., Ying Han, Ramkumar Rajamani, et al.. (2015). Biaryls as potent, tunable dual neurokinin 1 receptor antagonists and serotonin transporter inhibitors. Bioorganic & Medicinal Chemistry Letters. 25(15). 3039–3043. 5 indexed citations
3.
Ditta, Jonathan L., Derek J. Denhart, Jeffrey A. Deskus, et al.. (2013). Conformationally restricted homotryptamines. Part 6: Indole-5-cycloalkyl methylamines as selective serotonin reuptake inhibitors. Bioorganic & Medicinal Chemistry Letters. 23(10). 2948–2950. 2 indexed citations
4.
Denhart, Derek J., Dmitry Zuev, Jonathan L. Ditta, et al.. (2013). Potential CRF1R PET imaging agents: 1-Fluoroalkylsubstituted 5-halo-3-(arylamino)pyrazin-2(1H)-ones. Bioorganic & Medicinal Chemistry Letters. 23(7). 2052–2055. 4 indexed citations
5.
Luo, Guanglin, Ling Chen, Shuanghua Hu, et al.. (2013). Heterocyclic modification of a novel bicyclo[3.1.0]hexane NPY1 receptor antagonist. Bioorganic & Medicinal Chemistry Letters. 23(13). 3814–3817. 2 indexed citations
6.
Zuev, Dmitry, Ronald J. Mattson, Hong Huang, et al.. (2011). Potential CRF1R PET imaging agents: N-Fluoroalkyl-8-(6-methoxy-2-methylpyridin-3-yl)-2,7-dimethyl-N-alkylpyrazolo[1,5-a][1,3,5]triazin-4-amines. Bioorganic & Medicinal Chemistry Letters. 21(8). 2484–2488. 16 indexed citations
7.
Hartz, Richard A., Vijay T. Ahuja, William D. Schmitz, et al.. (2010). Synthesis and structure–activity relationships of N3-pyridylpyrazinones as corticotropin-releasing factor-1 (CRF1) receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 20(6). 1890–1894. 16 indexed citations
8.
Marcin, Lawrence R., Ronald J. Mattson, Qi Gao, et al.. (2009). Synthesis and hSERT activity of homotryptamine analogs. Part 6: [3+2] dipolar cycloaddition of 3-vinylindoles. Bioorganic & Medicinal Chemistry Letters. 20(3). 1027–1030. 6 indexed citations
9.
Denhart, Derek J., Jeffrey A. Deskus, Jonathan L. Ditta, et al.. (2009). Conformationally restricted homotryptamines. Part 5: 3-(trans-2-aminomethylcyclopentyl)indoles as potent selective serotonin reuptake inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(15). 4031–4033. 24 indexed citations
10.
Bruce, Marc A., Lawrence G. Iben, Gail K. Mattson, et al.. (2008). Pharmacological characterization and appetite suppressive properties of BMS-193885, a novel and selective neuropeptide Y1 receptor antagonist. European Journal of Pharmacology. 590(1-3). 224–232. 32 indexed citations
11.
Pieschl, Rick L., et al.. (2008). Ex vivo assessment of binding site occupancy of monoamine reuptake inhibitors: Methodology and biological significance. Neuropharmacology. 55(1). 63–70. 33 indexed citations
12.
Deskus, Jeffrey A., C.P. Sloan, Jingfang Qian‐Cutrone, et al.. (2007). Conformationally restricted homotryptamines 3. Indole tetrahydropyridines and cyclohexenylamines as selective serotonin reuptake inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(11). 3099–3104. 38 indexed citations
13.
King, Dalton, Derek J. Denhart, Jeffrey A. Deskus, et al.. (2007). Conformationally restricted homotryptamines. Part 4: Heterocyclic and naphthyl analogs of a potent selective serotonin reuptake inhibitor. Bioorganic & Medicinal Chemistry Letters. 17(20). 5647–5651. 19 indexed citations
14.
Gillman, Kevin W., Graham S. Poindexter, Wendy Clarke, et al.. (2006). Synthesis and evaluation of 5,5-diphenylimidazolones as potent human neuropeptide Y5 receptor antagonists. Bioorganic & Medicinal Chemistry. 14(16). 5517–5526. 17 indexed citations
15.
Mattson, Ronald J., John D. Catt, Derek J. Denhart, et al.. (2005). Conformationally Restricted Homotryptamines. 2. Indole Cyclopropylmethylamines as Selective Serotonin Reuptake Inhibitors. Journal of Medicinal Chemistry. 48(19). 6023–6034. 27 indexed citations
16.
Schmitz, William D., Derek J. Denhart, Allison B. Brenner, et al.. (2005). Homotryptamines as potent and selective serotonin reuptake inhibitors (SSRIs). Bioorganic & Medicinal Chemistry Letters. 15(6). 1619–1621. 20 indexed citations
17.
Luo, Guanglin, Gail K. Mattson, Marc A. Bruce, et al.. (2004). Isosteric N-arylpiperazine replacements in a series of dihydropyridine NPY1 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 14(24). 5975–5978. 16 indexed citations
18.
Ruel, Réjean, Timothy F. Herpin, Lawrence G. Iben, et al.. (2003). β-Alanine dipeptides as MC4R agonists. Bioorganic & Medicinal Chemistry Letters. 13(24). 4341–4344. 17 indexed citations
19.
Poindexter, Graham S., Marc A. Bruce, Ivo Monković, et al.. (2002). Dihydropyridine Neuropeptide Y Y1 Receptor Antagonists. Bioorganic & Medicinal Chemistry Letters. 12(3). 379–382. 30 indexed citations
20.
Mattson, Gail K., et al.. (1993). A practical approach to crosslinking. Molecular Biology Reports. 17(3). 167–183. 215 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026